Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
All you need to know about the 71st season of Europe's elite club competition.
Nyon - Friday 27 February 2026, 12:00 - your local time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results